Efficacy and safety of ARNI in high-risk patients in the PIONEER-HF trial5' education - Dec. 19, 2019 - Prof. David Morrow, MD - Boston, MA, USA
This video was recorded at the AHA in Philadelphia, USA, on November 17, 2019.
Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS), Boston, MA, USA.
This educational series is funded by an unrestricted educational grant provided by Novartis. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.